MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats. - Egyptian Knowledge Bank - troweb

76806

MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats.

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Molecular Study of The Therapeutic Effect of Pomegranate Peel Extract Against Non-Alcoholic Fatty Liver Disease in Rats .

Article

Effect of Pomegranate Juice against High Fat Diet Induced Fatty Liver in rats

Article

Protective Role of Pomegranate on Fatty Liver in Obesity: An Experimental Chemical & Histopathological Study

Article

Biochemical alterations of resveratrol on oxidative stress in experimental induced non - alcoholic fatty liver disease in rats

Article

EFFECT OF POLYPHENOLIC COMPOUNDS OF POMEGRANATE SEED AND PEEL ON HYPERLIPIDEMIC RATS

Article

Effect of Flaxseed on Experimentally Induced Non-Alcoholic Fatty Liver Disease in Albino Rats

Article

The Beneficial Effects of Silymarin in Treatment of Experimentally Induced Non-Alcoholic Fatty Liver Disease in Rats

Article

Effect some germinated on nonalcoholic fatty liver disease in albino rats

Article

Potential therapeutic effects of pomegranate peel on carbon tetrachloride induced liver injury in rat

Article

A hepatoprotective effect of an aqueous extract of pomegranate ( Punica granatum L. ) rind against acetaminop hen treated rats